Back to calendar
Enliven Therapeutics, Inc. (ELVN) Earnings
ELVN reports earnings on Wednesday, August 5, 2026
earnings report
August 5, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.43
Actual EPS: $-0.49
EPS surprise: -26.56%
Company overview
Market Cap$4.4B
PriceUSD 60.46
EPS (TTM)-1.67
52-week high62.32
52-week low14.79
SectorHealth Technology
IndustryBiotechnology
Employees60